Cervical Intraepithelial Neoplasia
📧 Sign up to get email alerts when something new happens for Cervical Intraepithelial Neoplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Does Hr-HPV Status Influence the 2011 IFCPC Nomenclature and Swede Score's Capacity to Diagnose Precancerous Lesions?
A completed clinical trial evaluated whether hr-HPV status influences the 2011 IFCPC nomenclature and Swede Score in diagnosing precancerous…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Engaging Practices and Communities in the Development of Interventions to Promote HPV Vaccine Uptake [NA]
A completed study from the University of Colorado, Denver investigates engaging practices and communities to develop interventions aimed at …
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3 [Phase 2]
Phase 2 clinical trial investigating the IRX-2 regimen for cervical intraepithelial neoplasia grade 3 and vulvar intraepithelial neoplasia g…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: An Innovative Treatment for Cervical Precancer (UH3) [NA]
A Cleveland Clinic-sponsored UH3 clinical trial investigating an innovative treatment for cervical intraepithelial neoplasia has completed, …
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: Multiple Human Papillomavirus Infections in the Development of CIN
Clinical trial update noting ongoing recruitment for a study examining how multiple human papillomavirus infections contribute to the develo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: The Adjuvant Effect of HPV Vaccination on Recurrence of Cervical Precancer or Carcinoma in Women Undergoing Conization
The study investigates whether adjuvant vaccination against human papillomavirus reduces recurrence of cervical intraepithelial neoplasia in…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Quality Control of Colposcopy Application
This completed clinical trial update reports on quality control aspects of a colposcopy application for assessing cervical cancer and cervic…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod [Phase 4]
Phase 4 trial evaluating clinical outcomes and biomarkers predicting immune response to imiquimod in cervical intraepithelial neoplasia grad…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age [Phase 1, Phase 2]
Phase 1/2 study evaluating the immune response and safety of an adjuvanted human papillomavirus vaccine in healthy women aged 16 to 26; resu…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women
This document reports long-term follow-up results from a study of the bivalent HPV vaccine in women. It discusses durability and potential o…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years [Phase 1]
Phase I clinical trial evaluating the safety of a 15-valent HPV vaccine in healthy Chinese adults aged 18-45. The study is currently active …
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment
An ecological assessment of the impact of HPV vaccination on cervical intraepithelial neoplasia and genital warts conducted in Colombia, whi…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia
The trial evaluates the use of plasma circulating HPV DNA testing to guide management of cervical intraepithelial neoplasia and cervical can…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions. [NA]
A completed clinical trial evaluated Papilocare Gel for repairing the cervico-vaginal mucosa in women with high-risk HPV lesions; the snippe…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Topical Curcumin for Precancer Cervical Lesions [Phase 2]
Phase 2 trial evaluating topical curcumin for precancerous cervical lesions has been terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) [Phase 3]
Phase 3 REVEAL 2 trial evaluating VGX-3100 delivered by electroporation for cervical HSIL completed, with results posted on 2024-10-17.
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia [NA]
The clinical trial evaluating physical cold atmospheric plasma for treating Cervical Intraepithelial Neoplasia has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: Epigallocatechin Gallate and Other Antural Compounds in HPV Infections [Phase 2]
A Phase 2 trial evaluating epigallocatechin gallate and other natural compounds for papilloma-induced cervical lesions related to HPV has be…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection [Phase 2]
Phase 2 trial evaluating 5-aminolevulinic acid–based photodynamic therapy (ALA-PDT) in CIN2 patients who are p16-positive and HPV high-risk …
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood
The trial evaluating self-collected menstrual blood as a screening method for cervical intraepithelial neoplasia has completed, with results…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR).
A completed clinical trial assessing the effectiveness of PAPILOCARE in regressing cervical HPV-related cytological abnormalities.
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) [Phase 2]
Phase 2 trial evaluating treatment of high-grade cervical intraepithelial neoplasia (CIN 2/3) has completed with results posted in May 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions [Phase 2]
Phase 2 clinical trial evaluation of Glizigen and Ocoxin-Viusid for high-grade cervical intraepithelial lesions is ongoing with an unknown s…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR) [Phase 4]
A Phase 4 clinical trial evaluates the efficacy of combining GLIZIGEN oral solution once daily with a vaginal gel nightly over 2 months in p…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions [Phase 2]
Phase 2 clinical trial comparing PepCan to two therapy arms for treating cervical high-grade intraepithelial lesions (CIN 2/3).